Abstract
Leptin, the product of the ob gene, is a recently discovered hormone secreted by adipocytes. Serum leptin concentrations increase in correlation with the percentage of body fat, but besides that little is known about the physiological actions of leptin in humans. The aim of this study was to assess the influence of changes in circulating free-fatty acids on serum leptin levels. Increases in plasma FFA levels (p<0.02) were obtained in a group of normal subjects following the administration of intralipid plus heparin (250 ml 10% Intralipid plus 5000 U heparin). FFA reduction was achieved through the administration of acipimox (250 mg, orally, at 0 min and at 210 min), a lipid-lowering drug devoid of side effects, to a group of normal (p<0.02) and obese subjects (p<0.05). An increase in circulating FFA levels in normal subjects (n=6), following administration of a lipid-heparin infusion, failed to modify plasma leptin levels as assessed by the area under the curve (AUC; mean±SE 892±168 for placebo vs 896±260 following intralipid plus heparin). Similarly, whereas acipimox pretreatment induced a reduction in FFA levels compared to placebo in normal (n=6) and obese subjects (n=8), it also failed to modify plasma leptin levels at any time-point studied. The results indicate that short-term reduction or increase in circulating FFA are not associated to changes in plasma leptin levels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Campfield L.A., Smith F.J., Guisez Y., Devos R., Burn P. Recombinant mouse OB protein evidence for a peripheral signal linking adiposity and central neural network. Science 269: 546, 1995.
Considine R.V., Considine E.L., Willians C.J., Nyce M.R., Magosin S.A., Bauer T.L., Rosato E.L., Colberg J., Caro J.F. Evidence against either a premature stop codon or the absence of obese mRNA in human obesity. J. Clin. Invest. 95: 2986, 1995.
Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., Friedman J.M. Weight-reducing effect of the plasma proteins encoded by the obese gene. Science 69; 543, 1995.
Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269; 540, 1995.
Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425, 1995. (Erratum Nature 374: 479, 1995).
Hamilton B.S., Paglia D., Kwan A.Y.M., Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med. 1: 953, 1995.
Lönnqvist F., Arner P., Nordfors L., Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med. 1: 950, 1995.
Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohanessian J.P., Marco C.C., McKee L.J., Bauer T.L., Caro J.F. Serum inmunoreactive-leptin concentrations in normal-weight and obese humans. N.Engl. J. Med. 334: 292, 1996.
Casanueva F.F., Dieguez C., Popovic V., Peino R., Considine R.V., Caro J.F. Serum inmunoreactive-leptin concentrations in patients with anorexia nervosa before and after partial weight recovery. Biochem. Mol. Med. 60: 116, 1997.
Jeanrenaud F.R., Jeanrenaud B. Obesity, leptin and the brain. N. Engl. J. Med. 334: 324, 1996.
Meier C.A. Leptin secretion and action: an update. Eur. J. Endocrinol 134: 543, 1996.
Wurtman R.J. What is leptin for, and does it act on the brain? Nature Med. 2: 492, 1996.
Trayhurn P., Rayner D.V. Hormones and the ob gene product (leptin) in the control of energy balance. Biochem. Soc. Trans. 24: 565, 1996.
Rentsch J., Chiesi M.I. Regulating of ob gene mRNA levels in cultured adipocytes. FEBS Lett. 379: 55, 1996.
Peino R., Cordido F., Peñalva A., Alvarez C.V., Dieguez C., Casanueva F.F. Acipimox-mediated plasma free-fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli. J. Clin. Endocrinol. Metab. 81: 909, 1995.
Cordido F., Peino R., Peñalva A., Alvarez C.V., Casanueva F.F., Dieguez C. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free-fatty acid depression. J. Clin. Endocrinol. Metab. 81: 914, 1995.
Sinha M.K., Ohanessian J.P., Heiman M.L., Kriauciunas A., Stephens T.W., Magosin S., Marco C., Caro J.F. Noctunal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J. Clin. Invest. 7: 1344, 1996.
Pombo M., Herrera-Justiniano E., Considine R.V., Hermida R.C., Galvez M.J., Martin T., Barreiro J., Casanueva F.F., Dieguez C. Nocturnal rise of leptin in normal prepubertal and pubertal children and in patients with perinatal stalk-transection syndrome. J. Clin. Endocrinol. Metab. 82: 2751, 1997.
Author information
Authors and Affiliations
Additional information
This work has been supported by grants from the Fondo de Investigacion Sanitaria, Spanish Ministry of Health and the Xunta de Galicia.
Rights and permissions
About this article
Cite this article
Peinò, R., Alvarez, J.F., Peñalva, A. et al. Acute changes in free-fatty acids (FFA) do not alter serum leptin levels. J Endocrinol Invest 21, 526–530 (1998). https://doi.org/10.1007/BF03347339
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347339